STOCK TITAN

Planned Rule 144 sale of 243,976 ALLO shares on NASDAQ

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

A planned sale notice under Rule 144 covers 243,976 shares of Common Stock, to be sold through Morgan Stanley Smith Barney LLC on the NASDAQ market. The shares have an aggregate market value of 438,522.46 and are part of a total of 224,730,144 shares outstanding.

The seller acquired these shares as restricted stock vesting under a registered plan from the issuer on 01/31/2026, treated as compensation. The approximate planned sale date is 02/02/2026, and the signer represents not knowing any undisclosed material adverse information about the issuer’s operations.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many ALLO shares are planned for sale in this Form 144?

The notice covers a planned sale of 243,976 shares of Common Stock. These shares were recently acquired through restricted stock vesting under a registered plan and are intended to be sold on NASDAQ through a designated broker.

What is the aggregate market value of the ALLO shares to be sold?

The aggregate market value of the 243,976 Common Stock shares covered by this notice is 438,522.46. This value reflects the total market worth of the planned sale at the time the notice information was prepared.

How were the ALLO shares in this Form 144 acquired?

The shares were acquired as restricted stock vesting under a registered plan from the issuer on 01/31/2026. The table identifies the nature of payment as compensation, indicating they were not purchased for cash in the open market.

When is the approximate sale date for the ALLO shares under Rule 144?

The notice lists an approximate date of sale of 02/02/2026. This indicates when the holder expects to begin selling the 243,976 Common Stock shares on NASDAQ through the named broker, subject to Rule 144 conditions.

How many ALLO shares are outstanding compared with this planned sale?

The filing shows 224,730,144 shares of Common Stock outstanding. The planned Rule 144 sale involves 243,976 shares, providing context for the relative size of the potential sale compared with the total outstanding share count.

Which broker will handle the ALLO Rule 144 share sale?

The planned sale will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004. This broker is listed for executing the NASDAQ transactions for the covered shares.
Allogene Therapeutics

NASDAQ:ALLO

ALLO Rankings

ALLO Latest News

ALLO Latest SEC Filings

ALLO Stock Data

366.31M
158.71M
17.45%
74.09%
8.99%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO